Jaguar Health Inc Share Price Nasdaq
Equities
US47010C3007
Biotechnology & Medical Research
Sales 2024 * | 15.11M 1.26B | Sales 2025 * | 22.66M 1.89B | Capitalization | 70.46M 5.88B |
---|---|---|---|---|---|
Net income 2024 * | -26M -2.17B | Net income 2025 * | -21M -1.75B | EV / Sales 2024 * | 4.66 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 3.11 x |
P/E ratio 2024 * |
-2.83
x | P/E ratio 2025 * |
-3.64
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 86.78% |
Latest transcript on Jaguar Health Inc
Managers | Title | Age | Since |
---|---|---|---|
Lisa Conte
FOU | Founder | 65 | 06/13/06 |
Carol Lizak
DFI | Director of Finance/CFO | 60 | 01/19/01 |
Chief Tech/Sci/R&D Officer | 60 | 01/17/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Lisa Conte
FOU | Founder | 65 | 06/13/06 |
James Bochnowski
CHM | Chairman | 80 | 01/14/01 |
John Micek
BRD | Director/Board Member | 71 | 01/16/01 |
1st Jan change | Capi. | |
---|---|---|
+7.52% | 113B | |
+11.38% | 106B | |
+1.02% | 22.27B | |
-12.64% | 22.22B | |
-5.29% | 19.43B | |
-37.85% | 17.87B | |
-8.58% | 17.24B | |
+7.77% | 14.29B | |
+37.41% | 12.52B |